The 2026 Healthtech Messaging Index

Rank#119of 302

Xsolis

xsolis.com·scored September 1, 2026

55out of 100

21/38

Invisible

The page is doing some work, but the story isn't landing fast enough. Buyers and AI are both left guessing what makes Xsolis different.

InvisibleAI recommends them? Yes
Xsolis homepage

The page we scored

The AI Recommendation Check

When we asked AI who to recommend for AI-powered utilization management and medical necessity decision support software for hospitals and health plans, it named:

Buyer we put in the prompt: VP of Revenue Integrity, Chief Financial Officer, or VP of Case Management at a mid-to-large U.S. hospital or health system. Both the buyer and the category were inferred from Xsolis’s homepage alone. The model had no web access.

Optum (InterQual)MCG HealthSolução (Utilization Management AI tools)Cerner (Oracle Health) UM toolsExperian HealthAvanza Healthcare SolutionsConduent Health

Xsolis was on the list.

AI named them for their own category. That's the signal every homepage is supposed to send.

AI named you when asked who it recommends for "AI-powered utilization management and medical necessity decision support software for hospitals and health plans", and described you accurately: "Xsolis is an AI-powered utilization management platform focused on helping hospitals reduce claim denials by providing real-time clinical data insights to support medical necessity determinations and improve collaboration between hospitals and payers.". Your positioning is landing with the machines.

Overall assessment

Xsolis's biggest strength is its proof stack ... five consecutive KLAS #1 awards, peer-reviewed studies, named health system logos, and concrete ROI numbers (5x-7x) give it exceptional third-party credibility that most competitors can't match. The biggest gap is the near-total absence of problem leadership and cost-of-inaction framing: the page never names the enemy (denial rates, fragmented workflows, payer disputes) in the buyer's language before pitching the solution, which means buyers who aren't already sold on the category have no emotional hook to stay.

Signal by category

Narrative Clarity

8 signals

5/16

Trust Signal

4 signals

6/8

AI Signal

6 signals

9/12

Conversion Signal

1 signal

1/2
0

Weakest signal · fix this first

02Rebellion / Movement

No named enemy, broken status quo, or industry pattern called out anywhere on the page.

The page never names what Xsolis is pushing against ... no 'the old way,' no named competitor pattern, no villain; it reads as capability marketing, not a movement.

All 19 signals, scored 0 to 2.

Narrative Clarity

8 signals

5/16
  • 01The 7-Second Test

    Better Mid-Cycle Outcomes, Powered by Intelligent Insights

    The headline requires healthcare revenue cycle knowledge to decode; a caveat stranger cannot instantly grasp who it serves, what problem it solves, or what POV it takes without reading the subhead.

    1
  • 02Rebellion / Movementweakest

    No named enemy, broken status quo, or industry pattern called out anywhere on the page.

    The page never names what Xsolis is pushing against ... no 'the old way,' no named competitor pattern, no villain; it reads as capability marketing, not a movement.

    0
  • 03Owned Language & Category

    Dragonfly" and "mid-revenue cycle" and "insight-driven workflows

    Dragonfly is a named product and 'mid-revenue cycle' hints at a category frame, but neither is explicitly claimed as an owned category or coined term that AI would uniquely attribute to Xsolis.

    1
  • 04ICP Clarity

    For Hospitals & Health Systems" and "For Health Plans & More" and "UR nurses, utilization managers, and case managers

    Two segments are named and specific roles are mentioned mid-page, but the hero doesn't surface ICP instantly ... company size, stage, and vertical are absent from the fold.

    1
  • 05Problem Leadership

    Better Mid-Cycle Outcomes, Powered by Intelligent Insights

    The hero leads with the solution and outcome framing, not the buyer's pain in the buyer's language; the problem (denials, fragmented data, variability) only surfaces in the subhead as secondary context.

    0
  • 06Solution Clarity

    Streamline medical necessity decisions, discharge planning, and payer-provider collaboration while actively preventing denials.

    The subhead gives a workable one-sentence description but packs too many concepts; most visitors could approximate what they do but not repeat it crisply.

    1
  • 07Cost of Inaction

    No mention of revenue lost to denials, cost of manual processes, or consequences of not acting anywhere on the page.

    The page never names the price of inaction ... no dollar figures lost, no denial rates, no operational pain that gets worse without Xsolis.

    0
  • 08Promised Land

    transforming data into measurable outcomes, not just documentation

    The promised land is vaguely gestured at with phrases like 'measurable outcomes' and 'sustained financial and operational improvement,' but no specific after-state (e.g., X% fewer denials, Y days shorter LOS) is painted for the buyer.

    1

Trust Signal

4 signals

6/8
  • 09Proof & Evidence

    5x-7x Average Customer ROI" ">9.5B Predictions and Growing" "615+ Hospitals" "95% Client Retention Rate

    Multiple concrete, specific numbers appear above the fold and are reinforced by peer-reviewed study references, making this one of the page's strongest trust signals.

    2
  • 10Social Proof

    Michele Greame, AVP of Revenue Integrity, Inova Health System" plus logos: Mayo Clinic, AdventHealth, BSW, MultiCare

    Named testimonial with title and organization, plus 11 recognizable named health system logos each linked to case studies, constitutes strong, specific social proof.

    2
  • 11Authority & Credibility

    KLAS Award 2021...2026" "#1 Physician Advisory Services Fourth Year" "Peer-Reviewed Studies Across Major U.S. Health Systems Validate AI

    Five consecutive years of KLAS #1 ranking plus peer-reviewed academic validation and a dozen named awards constitute demonstrated, third-party authority rather than claimed expertise.

    2
  • 12Alternatives Acknowledged

    No mention of competitors, alternative approaches, or 'do nothing' tradeoffs anywhere on the page.

    The page never acknowledges what buyers are currently doing instead ... no comparison to manual review, incumbent vendors, or status quo ... leaving a trust gap for skeptical buyers.

    0

AI Signal

6 signals

9/12
  • 13Customer Focus

    A team of executive, financial, and clinical subject matter experts ensures high user adoption while driving measurable outcomes.

    The page tilts toward company capabilities and what Xsolis does rather than consistently centering the customer's transformation; customer stories appear but the majority of copy is company-led.

    1
  • 14AI-Parmesan Index

    Dragonfly uses artificial intelligence to streamline mid-revenue cycle workflows and unify real-time clinical data.

    AI is mentioned repeatedly but the mechanism is described at a surface level ('reveals patterns and predictions'); it doesn't fully explain how the AI works, so it sits between vague sprinkle and genuine specificity.

    1
  • 15LLM Quotability

    Xsolis has been ranked #1 in Physician Advisory Services by KLAS for five consecutive years.

    A few quotable facts exist (KLAS #1, 5x-7x ROI, 9.5B predictions) but the hero and body copy are written in jargon-heavy prose that LLMs would paraphrase rather than quote verbatim.

    1
  • 16Copyright Freshness

    2026 in health care, AI: Trends facing an industry at a crossroads" and "KLAS Award 2026" image filenames dated 2026

    Multiple content items and award images reference 2025 and 2026, and press releases carry recent dates, signaling freshness to both human and AI readers.

    2
  • 17Entity Distinctiveness

    Purpose-built to see what others miss" "A dragonfly processes thousands of signals at once. So does Dragonfly." KLAS #1 five consecutive years

    The Dragonfly brand, the dragonfly analogy, the specific KLAS five-year streak, and the mid-revenue-cycle specialization combine to make this company distinguishable from generic utilization management competitors.

    2
  • 18AI Recommendation Check

    AI described you as: "Xsolis is an AI-powered utilization management platform focused on helping hospitals reduce claim denials by providing real-time clinical data insights to support medical necessity determinations and improve collaboration between hospitals and payers.

    AI named you when asked who it recommends for "AI-powered utilization management and medical necessity decision support software for hospitals and health plans", and described you accurately: "Xsolis is an AI-powered utilization management platform focused on helping hospitals reduce claim denials by providing real-time clinical data insights to support medical necessity determinations and improve collaboration between hospitals and payers.". Your positioning is landing with the machines.

    2

Conversion Signal

1 signal

1/2
  • 19Path & CTA Clarity

    SEE HOW IT WORKS" and "SEE DRAGONFLY IN ACTION" both link to /consult-request/

    There is a primary CTA and a secondary CTA but both drive to the same consult request with no numbered process or staged path explaining what happens next, so the conversion journey is incomplete.

    1

Keep the lead

AI already names Xsolis. The next edition decides if it still does.

Twenty minutes with Greg. Bring the page, bring the argument. You’ll leave knowing exactly which signal is costing Xsolis the AI recommendation, and what to write instead.

Not on the list? Run your homepage through the free Brand Signal Score and see where you’d land. Same 19 signals, same AI check, two minutes.

← Back to the full Healthtech index